• New, approved drugs as well as promising investigational agents: bendamustine HCl, ixabepilone, pentostatin (Nipent), satraplatin, triptorelin pamoate, fntanyl buccal tablets (Fentora), Duloxetine hydrochloride (Cymbalta), escitalopram (Lexapro), Posaconazole (Noxafil), and Anidulafungin (Eraxis).
• The most current thinking about molecular targeted therapy and epigenetics, with the following new drugs included: cediranib (Recentin), lapatinib (Tykerb), nilotinib (Tasigna), temsirolimus (Torisel), vandetanib (Zactima), and vorinostat (Zolinza).
• Section on Pain has been updated with the addition of fentanyl buccal tablets (Fentora).
• The most recent MASCC, ASCO and NCCN guidelines have been used to update the Nausea and Vomiting section.
• Specific drugs are described in terms of their mechanism of action, metabolism, drug interactions, laboratory effects/interference, and special considerations.
• Provides valuable information on effective symptom management and chemotherapy administration
• Inlcuded new guidelines for safe use of bisphosphonates.

Additionally, you'll get valuable added features, available only from Skyscape: